Search Results for: LVRN

10 interactions involving LVRN - laeverin found:

Sort by: Symbol Number of Pathways Number of Drugs Number of Diseases
Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
Novel COMMD10 COMM domain containing 10
  • Neddylation
Novel DTWD2 DTW domain containing 2
Novel FAM170A family with sequence similarity 170 member A
Novel PRR16 proline rich 16
Novel SEMA6A semaphorin 6A
  • Other semaphorin interactions
Novel SRFBP1 serum response factor binding protein 1
Novel TICAM2 toll like receptor adaptor molecule 2
  • Caspase activation via Death Receptors in the presence of ligand
  • Toll Like Receptor 4 (TLR4) Cascade
  • MyD88-independent TLR4 cascade
  • TRIF-mediated programmed cell death
  • Neutrophil degranulation
  • Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon
  • IKK complex recruitment mediated by RIP1
  • TRAF6-mediated induction of TAK1 complex within TLR4 complex
  • IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation
Novel TNFAIP8 TNF alpha induced protein 8
  • PI Metabolism
IFIT3 interferon induced protein with tetratricopeptide repeats 3
  • Interferon alpha/beta signaling
LMNA lamin A/C
  • XBP1(S) activates chaperone genes
  • Signaling by BRAF and RAF fusions
  • Restrictive dermopathy
  • Emery-Dreifuss muscular dystrophy
  • Dilated cardiomyopathy (DCM)
  • Charcot-Marie-Tooth disease (CMT); Hereditary motor and sensory neuropathy; Peroneal muscular atrophy
  • Mandibuloacral dysplasia
  • Congenital muscular dystrophies (CMD/MDC), including: Merosin-deficient CMD (MDC1A); Ullrich CMD (UCMD); Integrin alpha7-deficient CMD; CMD with joint hyperlaxity (CMDH); CMD with epidermolysis bullosa; Walker-Warburg syndrome (WWS); Muscle-eye-brain disease (MEB); Fukuyama CMD (FCMD); CMD with muscle hypertrophy (MDC1C); CMD with severe intellectual impairment and abnormal glycosylation (MDC1D); Rigid spine syndrome (RSS); LMNA-deficient CMD; CMD with respiratory failure and muscle hypertrophy (MDC1B); Bethlem myopathy
  • Limb-girdle muscular dystrophy (LGMD)
  • Familial partial lipodystrophy (FPL), including the following four diseases: Kobberling-type lipodystrophy (FPLD1); Dunnigan-type lipodystrophy (FPLD2); Dunnigan-like lipodystrophy (FPLD3); AKT2 associated lipodystrophy
  • Hutchinson-Gilford progeria syndrome

Page 1 out of 1 pages